KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Goodwill (2016 - 2019)

Historic Goodwill for Arbutus Biopharma (ABUS) over the last 5 years, with Q2 2019 value amounting to $22.5 million.

  • Arbutus Biopharma's Goodwill changed 0.0% to $22.5 million in Q2 2019 from the same period last year, while for Jun 2019 it was $22.5 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $22.5 million for FY2018, which is 776.97% down from last year.
  • Latest data reveals that Arbutus Biopharma reported Goodwill of $22.5 million as of Q2 2019, which was down 0.0% from $22.5 million recorded in Q1 2019.
  • Arbutus Biopharma's Goodwill's 5-year high stood at $162.5 million during Q4 2015, with a 5-year trough of $22.5 million in Q2 2018.
  • In the last 5 years, Arbutus Biopharma's Goodwill had a median value of $24.4 million in 2016 and averaged $76.5 million.
  • Within the past 5 years, the most significant YoY rise in Arbutus Biopharma's Goodwill was 426.59% (2016), while the steepest drop was 8500.81% (2016).
  • Quarter analysis of 5 years shows Arbutus Biopharma's Goodwill stood at $162.5 million in 2015, then tumbled by 85.01% to $24.4 million in 2016, then changed by 0.0% to $24.4 million in 2017, then decreased by 7.77% to $22.5 million in 2018, then changed by 0.0% to $22.5 million in 2019.
  • Its Goodwill stands at $22.5 million for Q2 2019, versus $22.5 million for Q1 2019 and $22.5 million for Q4 2018.